4-22387739-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_145290.4(ADGRA3):c.3932G>A(p.Arg1311Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000267 in 1,612,910 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000026 ( 0 hom. )
Consequence
ADGRA3
NM_145290.4 missense
NM_145290.4 missense
Scores
2
16
Clinical Significance
Conservation
PhyloP100: 4.32
Genes affected
ADGRA3 (HGNC:13839): (adhesion G protein-coupled receptor A3) This gene encodes a member of the G protein-coupled receptor superfamily. This membrane protein may play a role in tumor angiogenesis through its interaction with the human homolog of the Drosophila disc large tumor suppressor gene. This gene is mapped to a candidate region of chromosome 4 which may be associated with bipolar disorder and schizophrenia. [provided by RefSeq, Oct 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.030099332).
BS2
High AC in GnomAd4 at 5 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADGRA3 | NM_145290.4 | c.3932G>A | p.Arg1311Lys | missense_variant | 19/19 | ENST00000334304.10 | NP_660333.2 | |
ADGRA3 | XM_047449703.1 | c.3341G>A | p.Arg1114Lys | missense_variant | 19/19 | XP_047305659.1 | ||
ADGRA3 | XM_047449704.1 | c.3341G>A | p.Arg1114Lys | missense_variant | 19/19 | XP_047305660.1 | ||
ADGRA3 | XM_011513811.3 | c.3254G>A | p.Arg1085Lys | missense_variant | 14/14 | XP_011512113.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADGRA3 | ENST00000334304.10 | c.3932G>A | p.Arg1311Lys | missense_variant | 19/19 | 1 | NM_145290.4 | ENSP00000334952.5 | ||
ADGRA3 | ENST00000282943.9 | n.3503G>A | non_coding_transcript_exon_variant | 17/17 | 1 | |||||
ADGRA3 | ENST00000499527.6 | n.3629G>A | non_coding_transcript_exon_variant | 3/3 | 1 | |||||
ADGRA3 | ENST00000511051.5 | n.104+1349G>A | intron_variant | 3 | ENSP00000424927.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152190Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
5
AN:
152190
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000479 AC: 12AN: 250480Hom.: 0 AF XY: 0.0000739 AC XY: 10AN XY: 135388
GnomAD3 exomes
AF:
AC:
12
AN:
250480
Hom.:
AF XY:
AC XY:
10
AN XY:
135388
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1460602Hom.: 0 Cov.: 31 AF XY: 0.0000454 AC XY: 33AN XY: 726476
GnomAD4 exome
AF:
AC:
38
AN:
1460602
Hom.:
Cov.:
31
AF XY:
AC XY:
33
AN XY:
726476
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74466
GnomAD4 genome
AF:
AC:
5
AN:
152308
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
74466
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
5
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 20, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1024892). This variant has not been reported in the literature in individuals affected with ADGRA3-related conditions. This variant is present in population databases (rs543888546, gnomAD 0.04%). This sequence change replaces arginine, which is basic and polar, with lysine, which is basic and polar, at codon 1311 of the ADGRA3 protein (p.Arg1311Lys). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MutPred
Gain of methylation at R1311 (P = 0.0155);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at